BG
IONS icon

BlackRock Group’s Ionis Pharmaceuticals IONS Stock Holding History

BlackRock Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.66M Buy
118,228
+17,397
+17% +$688K ﹤0.01% 1122
2016
Q3 		$3.69M Sell
100,831
-393,863
-80% -$12.3M ﹤0.01% 1259
2016
Q2 		$11.5M Sell
494,694
-266,669
-35% -$8.6M 0.01% 886
2016
Q1 		$30.8M Sell
761,363
-88,315
-10% -$3.59M 0.02% 698
2015
Q4 		$52.6M Buy
849,678
+190,688
+29% +$10.3M 0.03% 567
2015
Q3 		$26.6M Sell
658,990
-37,573
-5% -$1.94M 0.02% 708
2015
Q2 		$40.1M Sell
696,563
-272,738
-28% -$17.3M 0.02% 658
2015
Q1 		$61.7M Buy
969,301
+491,448
+103% +$33.3M 0.03% 540
2014
Q4 		$29.5M Buy
477,853
+413,008
+637% +$20.4M 0.02% 711
2014
Q3 		$2.52M Sell
64,845
-4,387
-6% -$155K ﹤0.01% 1332
2014
Q2 		$2.38M Sell
69,232
-178,861
-72% -$5.63M ﹤0.01% 1382
2014
Q1 		$10.7M Sell
248,093
-15,390
-6% -$746K 0.01% 909
2013
Q4 		$10.5M Sell
263,483
-96,322
-27% -$3.43M 0.01% 906
2013
Q3 		$13.5M Buy
359,805
+73,122
+26% +$2.18M 0.01% 864
2013
Q2 		$7.7M Buy
+286,683
New +$6.1M 0.01% 907

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's IONS Position: Q4 2016 in Review

BlackRock Group increased its Ionis Pharmaceuticals (IONS) stake by 17% in Q4 2016, buying an estimated $688K and bringing the position to 118,228 shares worth $5.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

BlackRock Group first reported a position in IONS in Q2 2013 and has held it in 15 quarters since. The position peaked at $61.7M in Q1 2015. 308 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

  • BlackRock Group held 118,228 shares of Ionis Pharmaceuticals worth $5.66M as of Q4 2016.
  • BlackRock Group bought 17,397 Ionis Pharmaceuticals shares in Q4 2016, an estimated $688K.
  • Ionis Pharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1122 holding.
  • BlackRock Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Ionis Pharmaceuticals position peaked at $61.7M in Q1 2015.
  • 308 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.